Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
暂无分享,去创建一个
V. Georgoulias | E. Stathopoulos | J. Souglakos | A. Polyzos | A. Christopoulou | K. Kalbakis | A. Kotsakis | N. Kentepozidis | D. Hatzidaki | O. Katopodis | E. Kontopodis